Description: Nuvo Pharmaceuticals Inc., doing business as Miravo Healthcare, operates as a healthcare company with focus on Canada. The company's products target therapeutic areas such as pain, allergy, and dermatology. It in-licenses and acquires complementary products for Canadian and international markets; and out-licenses select products in global markets. The company operates through three segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The company was formerly known as Nuvo Research Inc. and changed its name to Nuvo Pharmaceuticals Inc. in March 2016. Nuvo Pharmaceuticals Inc. was founded in 1983 and is headquartered in Mississauga, Canada with an office for international operations in Dublin, Ireland and a manufacturing facility in Varennes, Canada.
Home Page: www.miravohealthcare.com
MRV Technical Analysis
6733 Mississauga Road
Mississauga,
ON
L5N 6J5
Canada
Phone:
905 673 6980
Officers
| Name | Title |
|---|---|
| Mr. Jesse F. Ledger | Pres & CEO |
| Ms. Mary-Jane E. Burkett C.A., CPA, HBA | VP & CFO |
| Dr. Bernard Joseph Chiasson Ph.D. | VP of Operations & Chief Scientific Officer |
| Ms. Katina K. Loucaides M.Sc., LL.B | VP, Corp. Sec. & Gen. Counsel |
| Mr. Luigi Berardelli | VP of Sales & Marketing |
Exchange: TO
Country: CA
Currency: Canadian Dollar (C$)
| Forward PE: | 2.7503 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.8858 |
| Price-to-Sales TTM: | 0.1038 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 101 |